Tevard Biosciences, Inc., a privately held biotechnology company pioneering tRNA-based therapies to cure a broad range of genetic diseases, today announced the presentation of new preclinical data ...

Clinical benefit for efzofitimod across multiple disease-related health outcomes reported. Improvement in Fatigue Assessment Scale Total Score at week 48 observed in the 5.0 mg/kg efzofitimod ...

A recent study conducted by researchers at Queen Mary University of London unveiled a new mechanism through which cells control aging. With simple fission yeast, the scientists showed that Rapalink-1, ...

Northwestern University has announced a new method for detecting RNA modification patterns to enhance early colon cancer detection.

Dr. Yeon Soo Kim, a postdoctoral fellow in Dr. Andrew Hsieh’s lab at Fred Hutch, has won a NIH Pathway to Independence Award to study how advanced prostate cancer evades therapy by altering the way ...